Immunovant Correlations
IMVT Stock | USD 17.91 0.37 2.02% |
The current 90-days correlation between Immunovant and Krystal Biotech is 0.63 (i.e., Poor diversification). The correlation of Immunovant is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Immunovant Correlation With Market
Very weak diversification
The correlation between Immunovant and DJI is 0.42 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Immunovant and DJI in the same portfolio, assuming nothing else is changed.
Immunovant | Build AI portfolio with Immunovant Stock |
Moving together with Immunovant Stock
0.66 | JNJ | Johnson Johnson | PairCorr |
0.7 | MRK | Merck Company | PairCorr |
0.79 | PFE | Pfizer Inc | PairCorr |
0.65 | KMDA | Kamada | PairCorr |
0.71 | NKTR | Nektar Therapeutics | PairCorr |
0.67 | CGEN | Compugen | PairCorr |
0.69 | FNMFO | Federal National Mortgage | PairCorr |
0.68 | KB | KB Financial Group Earnings Call Tomorrow | PairCorr |
0.79 | SHG | Shinhan Financial Earnings Call This Week | PairCorr |
0.83 | WF | Woori Financial Group Earnings Call This Week | PairCorr |
0.81 | BAC-PL | Bank of America | PairCorr |
0.65 | WFC-PL | Wells Fargo | PairCorr |
0.64 | CSCO | Cisco Systems | PairCorr |
0.61 | INTC | Intel Earnings Call This Week | PairCorr |
0.61 | MSFT | Microsoft | PairCorr |
0.77 | CVX | Chevron Corp | PairCorr |
Moving against Immunovant Stock
0.5 | BCH | Banco De Chile | PairCorr |
0.53 | PG | Procter Gamble | PairCorr |
0.39 | TRV | The Travelers Companies | PairCorr |
0.37 | HPQ | HP Inc | PairCorr |
0.31 | KO | Coca Cola Earnings Call This Week | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Immunovant Stock performing well and Immunovant Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Immunovant's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
ROIV | 1.52 | 0.08 | 0.03 | 0.22 | 1.66 | 3.29 | 9.33 | |||
KRYS | 1.92 | (0.39) | 0.00 | (0.11) | 0.00 | 4.17 | 18.32 | |||
AKRO | 2.48 | 0.49 | 0.15 | 1.05 | 2.56 | 5.49 | 30.05 | |||
APLS | 2.49 | (0.06) | (0.03) | 0.06 | 2.70 | 5.62 | 18.33 | |||
REPL | 3.61 | 0.75 | 0.13 | 0.97 | 4.89 | 9.93 | 34.70 | |||
PCVX | 3.04 | 0.05 | 0.03 | 0.16 | 3.65 | 6.93 | 21.28 | |||
IGMS | 3.14 | 0.03 | 0.02 | 0.15 | 3.77 | 6.72 | 25.54 | |||
RVMD | 1.95 | 0.00 | (0.01) | 0.13 | 2.49 | 3.61 | 18.30 |
Immunovant Corporate Management
Jay Stout | Chief Officer | Profile | |
Mark Levine | Chief Secretary | Profile | |
Lauren MBA | Vice Marketing | Profile | |
JD Esq | Chief Secretary | Profile | |
Eva MBA | Chief Officer | Profile | |
Julie Kirschling | Senior Management | Profile | |
Christine Blodgett | Senior Resources | Profile |